80 results
8-K
EX-99.1
IMCR
Immunocore Holdings plc
31 May 24
Regulation FD Disclosure
4:21pm
and is associated with the vast majority of skin cancer-related mortality. The majority of patients with CM are diagnosed before metastasis and survival remains
8-K
EX-99.1
IMCR
Immunocore Holdings plc
30 May 24
Other Events
5:22pm
. It is the most aggressive skin carcinoma and is associated with the vast majority of skin cancer-related mortality. The majority of patients with CM
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
of materials and contract manufacturing services. While the majority of such contracts can be cancelled on reasonable notice, due to the significant ongoing … at the annual ASCO meeting on May 31, 2024. These patients were all previously treated with anti-PD1 and the vast majority having received ipilimumab. We
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
is present, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present … by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who are entitled to vote and vote
8-K
EX-5.1
IMCR
Immunocore Holdings plc
5 Apr 24
Other Events
4:35pm
Directors to vote), a quorum was present throughout, the requisite majority of Directors voted in favour of approving the resolutions and the resolutions
424B7
uagu90w2
5 Apr 24
Prospectus with selling stockholder info
4:34pm
PRE 14A
kbodh2j7r5ldkvf91b2
2 Apr 24
Preliminary proxy
4:45pm
S-8
EX-5.1
v8n1fowtg06h1k0
20 Mar 24
Registration of securities for employees
8:55pm
S-3ASR
fcimv1t g9oenxq
20 Mar 24
Automatic shelf registration
8:51pm
S-3ASR
EX-5.2
6ng734b6jtd2rio
20 Mar 24
Automatic shelf registration
8:51pm
S-3ASR
EX-5.1
ieq7zja7a
20 Mar 24
Automatic shelf registration
8:51pm
10-K
EX-97.1
x0fjlt md
28 Feb 24
Annual report
7:33am
10-K
itcrdo zop
28 Feb 24
Annual report
7:33am
8-K
EX-4.1
0ercpra mv
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-99.2
u5i 90pkngg
5 Jan 24
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
7:19am
6-K
EX-99.1
0q4ke24h6
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
dml1i0cwis71cpa1z9d2
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.1
9vp8q6
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
fvnmmf
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
m8gvz2udo
10 May 23
Current report (foreign)
7:27am